Form 4 for SLSN SOLESENCE, INC.
Accepted 2022-11-28 00:00:00 ET · period of report 2022-11-23 · accession 0001209191-22-058923 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-11-28 | 2022-11-23+ | SLSN | JANKOWSKI JESS | Pres, CEO, Dir | M - OptEx | $0.42 | +4,500 | 60.5K | +8% | +$1,890 |
| DM | 2022-11-28 | 2022-11-23+ | SLSN | JANKOWSKI JESS | Pres, CEO, Dir | S - Sale+OE | $1.39 | -4,500 | 59.0K | -7% | -$6,270 |
| DM | 2022-11-28 | 2022-11-23+ | SLSN | JANKOWSKI JESS | Pres, CEO, Dir | M - OptEx | $0.42 | -4,500 | 27.1K | -14% | -$1,890 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-25 | M | A | 3,000 | $0.42 | 62,000 | D | — | — | (F1) These stock options are set to expire on 02/14/2023. Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors. |
| 2 | Common | Common Stock | 2022-11-23 | M | A | 1,500 | $0.42 | 60,500 | D | — | — | (F1) These stock options are set to expire on 02/14/2023. Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors. |
| 3 | Common | Common Stock | 2022-11-23 | S | D | 1,500 | $1.40 | 59,000 | D | — | — | (F2) If not sold through a 10b5-1 Plan, Nanophase trading blackout periods run from the 25th of the last day of any given quarter until 3 days after earnings are released. In example, for options expiring during the 1st quarter of any given year, trading would be prohibited from December 25th of the prior year, through the release of annual earnings plus 3 business days. Typically, this would reopen trading in early-to-mid March, through March 24th. The next blackout period would begin on March 25th, etc. (F3) The price reported is a weighted average price. These shares were sold through multiple transactions, five in all, at prices ranging from $1.40 to $1.40. |
| 4 | Common | Common Stock | 2022-11-25 | S | D | 3,000 | $1.39 | 59,000 | D | — | — | (F2) If not sold through a 10b5-1 Plan, Nanophase trading blackout periods run from the 25th of the last day of any given quarter until 3 days after earnings are released. In example, for options expiring during the 1st quarter of any given year, trading would be prohibited from December 25th of the prior year, through the release of annual earnings plus 3 business days. Typically, this would reopen trading in early-to-mid March, through March 24th. The next blackout period would begin on March 25th, etc. (F4) The price reported is a weighted average price. These shares were sold through multiple transactions, four in all, at prices ranging from $1.35 to $1.41. |
| 5 | Derivative | Common Stock (right to purchase) | 2022-11-23 | M | D | 1,500 | $0.42 | 30,126 | D | $0.42 · 2014-02-14 to 2023-02-14 | 31,626 Common Stock | (F5) These stock options are set to expire on 02/14/2023. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker. His goal is to have this broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors. |
| 6 | Derivative | Common Stock (right to purchase) | 2022-11-25 | M | D | 3,000 | $0.42 | 27,126 | D | $0.42 · 2014-02-14 to 2023-02-14 | 30,126 Common Stock | (F5) These stock options are set to expire on 02/14/2023. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker. His goal is to have this broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors. |